A new position statement from the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) highlights “Challenges in and Opportunities for Individualizing Diabetes Technology”
The Diabetes Technology Working Group for the EASD and ADA have released a position statement about diabetes technology.
This paper explains how diabetes technologies (e.g. insulin pumps, glucose monitors, and closed-loop devices) are changing how diabetes is managed. These tools can help people:
-
- manage their glucose levels
- reduce risk of complications
- improve quality of life
The statement describes features of diabetes devices, and what to think about when selecting them. There is no “one-size-fits-all” approach. Health professionals need to work with people with diabetes to support them to choose devices that suit them. For example:
-
- Does the person want to use the device?
- Will it help them to meet their personal goals / diabetes targets?
- Is it available?
- Is it affordable?
- Is it easy to use? Consider, for example: digital literacy; health literacy; physical, cognitive and emotional status; and daily routine.
The statement suggests ways to introduce and implement diabetes technology. Practical action points that health professionals can use in their clinical practice include:
-
- provide education to support decision making and use of devices
- give people with diabetes chances to ask questions
- set up a trial to help the person make a decision that suits them
- provide ongoing support to help ensure safe and effective use over time
Diabetes technology can offer benefits to people with diabetes. Benefits will be best achieved if devices are carefully chosen, and ongoing support is given. The statement is recommended reading for all diabetes health professionals.
Reference:
Daniela Bruttomesso, John R. Petrie, Mark Evans, G. Alexander Fleming, Helene Hanaire, Reinhard W. Holl, Jennifer L. Sherr, Richard M. Bergenstal, Lutz Heinemann, Anne L. Peters; Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetes Care 20 May 2026; 49 (6): 916–930. https://doi.org/10.2337/dci26-0018
AI technology (Microsoft Copilot, in June 2026) was used to prepare an early draft of this blog. All AI-generated output was critically reviewed and edited substantially to enhance accuracy, clarity and readability, resulting in the version published here.
Print This Post